Lyell Immunopharma, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC LYEL

Report date

3/31/2025

Quarter

2025 Q1

Filed

9/15/2025

Shares

1,604,676

Value ($000)

863

Weight

0.0%

2021 Q3 - 2025 Q1 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	9/15/2025	863	0.0%	1,604,676	3/31/2025
2024 Q4	2/6/2025	1,053	0.0%	1,645,787	12/31/2024
2024 Q3	11/12/2024	1,583	0.0%	1,147,370	9/30/2024
2024 Q2	8/12/2024	1,882	0.0%	1,297,642	6/30/2024
2024 Q1	5/9/2024	2,853	0.0%	1,279,412	3/31/2024
2023 Q4	2/6/2024	2,458	0.0%	1,266,863	12/31/2023
2023 Q3	11/8/2023	1,839	0.0%	1,250,711	9/30/2023
2023 Q2	8/10/2023	3,663	0.0%	1,152,009	6/30/2023
2023 Q1	5/12/2023	2,689	0.0%	1,139,474	3/31/2023
2022 Q4	2/13/2023	3,931	0.0%	1,132,856	12/31/2022
2022 Q3	11/14/2022	8,152	0.0%	1,112,110	9/30/2022
2022 Q2	8/15/2022	3,190	0.0%	489,207	6/30/2022
2022 Q1	5/13/2022	2,289	0.0%	453,144	3/31/2022
2021 Q4	2/11/2022	1,326	0.0%	171,206	12/31/2021
2021 Q3	11/16/2021	2,461	0.0%	166,255	9/30/2021